Journal of Vascular Surgery
Volume 30, Issue 1 , Pages 200-202, July 1999

Disclosure of competition of interest☆☆☆

Toronto, Ontario, Canada, and Silverthorne, Colo

From the Toronto General Hospital and the Department of Surgery, Vascular Surgery Section, University of Colorado Health Sciences Center

Received 8 June 1999

Article Outline

Abstract 

J Vasc Surg 1999;30:200-2.

 

In recent years, to maintain the trust that the public has in the medical profession and scientific research, public accountability and clarity of relationships have become more important.1 In this regard, addressing the problem of conflict of interest is one of the important issues.

As of this issue, the Journal of Vascular Surgery will join many other major medical journals in requiring authors to disclose financial and other potential competitive interests.2 In justifying the introduction of routine disclosure of “competitive interests” in the British Medical Journal in 1998, Richard Smith3, 4 reviewed the mounting studies that suggest that authors may develop an unconscious professional bias that is influenced by secondary factors, often financial gain.5, 6, 7 As suggested by Smith, we will use the terms “competition of interest” or “competitive interests” rather than conflict of interest to emphasize our belief that it is not intentionally deceitful conduct but rather inherent in human interaction.

In the Instructions to Authors, the Journal of Vascular Surgery asks its authors to declare any conflicts of interest that might impact their work. However, over the past 2 years, few have made such a disclosure. Although the source of non-governmental or non-foundation funding has been declared, authors have rarely disclosed personal financial interests (ie, equity holdings, honoraria, patents, consultancies, or scientific advisory board memberships). We believe that this low level of disclosure in the JVS needs to be addressed.8

In changing our policy and requesting requiring authors, editors, and editorial board members to declare any competition of interest, the following explain our views on this complex issue.

Competition of interest is defined as a circumstance or situation that is present if the author's views or conclusions might unintentionally be influenced by secondary factors, such as the potential for financial profit, personal conflict, academic gain, or beliefs.

Although there are several potential sources of competition of interest, for pragmatic reasons, we will ask authors to disclose potential financial competition of interest, which is generally regarded as the most relevant.

We do not believe that competition of interest is inherently wrong. As expressed by Brody,9 it is common; there is nothing fundamentally wrong with having interests that compete or conflict. Brody states “The existence of conflicting loyalties has always been a part of the patient-physician relation. Physicians, have, in addition to their obligation to any individual patient, obligations to their other patients, to their families, to themselves, to society, their religion, etc. Like everyone else, physicians live in a tangled web of conflicting obligations.”9

Because some degree of competition of interest is inescapable in most papers, the most practical approach to reducing the risk that the overall quality of a paper is reduced by unconscious biased decisions in the design, implementation, analysis, or discussion of the research is to ask the authors to disclose potential competitive interests to the readers. Through disclosure, competitive interests are made transparent. Consequently, the readers can assess the magnitude of the competition and add this to their overall interpretation of the published work.

Even though disclosure of potential financial interests is emphasized (eg, equity holdings, payment for corporate consultations), it is important to recognize that grant support to individuals or institutions from either industry or the public sector may also be an important source of competition of interest. Grants provide funding for the research proposal but may also provide overhead to support the institution and “profit” to support other unrelated research projects and thereby potentially contribute to academic advancement.

With the goal of providing readers with information that may help them judge the application of the data in the paper to their practice, we will now ask the authors to make the following disclosures.

1.Acknowledge the authors' university, institutional, or corporate affiliations.

2.List all sources of funding for the research project from national or local agencies, the institution, companies, and other sources. Also, it may be appropriate for an author to declare the sources of funding that have supported previous or other work that might have influenced their views expressed in the paper.

3.Disclose any financial associations that might represent a competition of interest in respect to the manuscript, such as a consulting or employment arrangement or a royalty or stock agreement with the company. If a paper is accepted for publication, the authors will be asked to draft and attach a competition of interest statement that may be published as a footnote with the article. For example, it might read as follows: “KR has been paid a consulting fee by XYZ Company and is on their speakers bureau; PW has shares in the company; RC received funding for a research assistant from the XYZ Company.” Also, the authors have the opportunity to disclose personal, academic, or other possible conflicts.

The form that will be sent to the authors of accepted papers is printed on the next page. In summary, competition of interests is inevitable but may subconsciously influence an author's study design, interpretation of results, or opinions expressed in a published article. It is therefore reasonable to ask the authors to disclose them. There are several potential sources of competition, but for pragmatic reasons, we will ask authors to disclose potential financial competition, after the paper has been accepted for publication. We will start phasing in this policy with this issue. Also, on a yearly basis, the editors and members of the editorial board will be asked to disclose any competition of interest. We are requesting our readers to judge the impact of this policy and through feedback from them over time, we will determine whether this new policy provides added greater perspective and accountability.

Back to Article Outline

Competition of Interest Statement 

To be signed by all authors after acceptance of paper

For all accepted manuscripts, editorials, comments, and letters, please answer the following questions for each author.

1.Are the author's university, institutional, and corporate affiliations included in the paper/letter?Yes ___No ___ (attach correction)

2.Are all the applicable sources of funding for the project included in the paper/letter?Yes ___No ___ (attach correction)

3.For each author, is the answer to any of the following questions ‘yes'?

1.Have you received a financial contribution from a company or organization that might benefit (or lose) financially from the results, conclusions or discussion presented in your paper/letter? Specifically have you received funds for research (other than listed in the acknowledgment #2 above)
•royalties

•patent (or patent pending)

•a fee for consulting

•a fee for speaking when organized by a speakers bureau

•funds for a member of your staff

•Do you own stocks, shares or have options in a company or organization that might benefit (or lose) financially from the results, conclusion or discussion presented in your paper/letter?

•Do you have any other competing financial interests that you would like to disclose? Yes* ___No ___ *If ‘yes', please draft and attach a competition of interest statement that might be published as a footnote with the article. For example, it might read as follows. “KR has been paid a consulting fee by XYZ Company and is on their speakers bureau; PW has shares in the company; RC received funding for a research assistant from the XYZ Company.”

 Although we are emphasizing financial disclosure, each author may choose to disclose other potential conflicts which could include an academic association or antagonism with someone whose interest might be affected by your publication, membership in a special interest group whose interests might be affected by your paper, or other strong convictions that might have affected what you wrote.

Name____________________________________Signature____________________________________ Date____________________________________ Please fax and send original by mail

Back to Article Outline

References 

  1. Spece RG, Shimm DS, Buchanan AE. Conflicts of interest in clinical practice. New York: Oxford University Press; 1996;
  2. International Committee of Editors of Biomedical Journals . Uniform requirements for manuscripts submitted to biomedical journals. JAMA. 1997;277:927–934
  3. Smith R. Conflict of interest and the BMJ. BMJ. 1994;308:4–5
  4. Smith R. Beyond conflict of interest. BMJ. 1998;317:291–292
  5. Stelfox HT. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998;338:101–105
  6. Rochon PA. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994;154:157–163
  7. Barnes DF. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998;279:1566–1570
  8. Krimsky S, Rothenberg LS, Stott P, Kyle G. Scientific journals and their authors' financial interests: a pilot study. Psychother Psychosom. 1998;67:194–201
  9. Brody B. Special ethical issues in the management of PVS patients. Law Med Health Care. 1992;20:113

☆ Reprint requests: Dr K. Wayne Johnston, Editorial Office, Toronto General Hospital, 5 Eaton, Room 312, 200 Elizabeth St, Toronto, Ontario, M5G 2C4, Canada.

☆☆ 24/39/466

PII: S0741-5214(99)70195-3

Journal of Vascular Surgery
Volume 30, Issue 1 , Pages 200-202, July 1999

Article Tools